Rocket Pharmaceuticals (RCKT) Shares Issued (2015 - 2024)

Rocket Pharmaceuticals has disclosed Shares Issued across 9 years of filings, most recently posting $321000.0 for Q4 2024.

• Shares Issued for Q4 2024 came in at $321000.0, up 118.02% year-over-year; the trailing twelve-month figure through Sep 2025 was $321000.0 (down 71.06% YoY), and the FY2024 annual result was $3.2 million, up 5251.67% from the prior year.
• Shares Issued came in at $321000.0 for Q4 2024 at Rocket Pharmaceuticals, up from $176000.0 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $280.8 million in Q4 2020 to a low of -$8.8 million in Q2 2021.
• The 5-year median for Shares Issued is $179000.0 (2023), against an average of $17.8 million.
• Peak annual rise in Shares Issued reached 16488.68% in 2021, while the deepest fall reached 17484.0% in 2021.
• Rocket Pharmaceuticals' Shares Issued stood at $280.8 million in 2020, then sank by 103.13% to -$8.8 million in 2021, then surged by 99.1% to -$79000.0 in 2022, then sank by 2154.43% to -$1.8 million in 2023, then jumped by 118.02% to $321000.0 in 2024.
• The last three Shares Issued figures came in at $321000.0 (Q4 2024), $176000.0 (Q3 2024), and $1.5 million (Q2 2024), per Business Quant data.